Andrew Koven

Andrew Koven

Chairman bei NEUROBO PHARMACEUTICALS, INC.

Vermögen: 22 368 $ am 31.03.2024

66 Jahre
Health Technology
Consumer Services
Technology Services

Profil

Andrew Ian Koven is currently the Chairman at NeuroBo Pharmaceuticals, Inc. since 2022 and the Lead Independent Director at KALA BIO, Inc. since 2018.
Previously, he held positions such as President, Director & Chief Administrative Officer at Neurologix, Inc. in 2011, Secretary, Executive VP & General Counsel at Sumitomo Pharma America, Inc. from 2007 to 2010, and Associate General Counsel at Warner-Lambert Co. from 1993 to 2000.
He also served as Secretary, Executive VP & General Counsel at KOS Pharmaceuticals, Inc. from 2003 to 2006, Chief Administrative & Legal Officer, Executive VP at Inspire Pharmaceuticals, Inc. from 2010 to 2011, President & Chief Business Officer at POZEN, Inc. from 2015 to 2016, Secretary, CAO, Executive VP & General Counsel at Auxilium Pharmaceuticals LLC from 2012 to 2015, and Corporate & Securities Associate at Cahill Gordon & Reindel LLP from 1986 to 1992.
Additionally, he was Senior Vice President & General Counsel at Lavipharm Corp.
from 2000 to 2003, Counsel-Corporate & Investment Division at Equitable Financial Life Insurance Co. from 1992 to 1993, and Secretary, Senior Vice President & General Counsel at Lavipharm Laboratories, Inc. from 2000 to 2003.
He also served as President & Chief Business Officer at Old API Wind-down Ltd.
from 2015 to 2019.
Mr. Koven obtained his undergraduate degree from Dalhousie University in 1978, his graduate degree from Dalhousie University in 1981, and his graduate degree from Columbia Law School.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
25.03.2024 5 469 ( 0,11% ) 22 368 $ 31.03.2024

Aktive Positionen von Andrew Koven

UnternehmenPositionBeginn
KALA BIO, INC. Director/Board Member 28.09.2017
NEUROBO PHARMACEUTICALS, INC. Chairman 14.01.2022
Alle aktiven Positionen von Andrew Koven

Ehemalige bekannte Positionen von Andrew Koven

UnternehmenPositionEnde
OLD API WIND-DOWN LTD. President 31.01.2019
POZEN INC. President 01.02.2016
AUXILIUM PHARMACEUTICALS, INC. Chief Administrative Officer 01.01.2015
NEUROLOGIX, INC. President 30.11.2011
Chief Administrative Officer 01.05.2011
Sehen Sie sich die Erfahrung von Andrew Koven im Detail an

Ausbildung von Andrew Koven

Dalhousie University Undergraduate Degree
Columbia Law School Graduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Andrew Koven im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

16

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen2
KALA BIO, INC.

Health Technology

NEUROBO PHARMACEUTICALS, INC.

Health Technology

Private Unternehmen12

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Miscellaneous

Lavipharm Laboratories, Inc.

Health Technology

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Andrew Koven